JP2023537070A5 - - Google Patents

Info

Publication number
JP2023537070A5
JP2023537070A5 JP2023508555A JP2023508555A JP2023537070A5 JP 2023537070 A5 JP2023537070 A5 JP 2023537070A5 JP 2023508555 A JP2023508555 A JP 2023508555A JP 2023508555 A JP2023508555 A JP 2023508555A JP 2023537070 A5 JP2023537070 A5 JP 2023537070A5
Authority
JP
Japan
Prior art keywords
seq
domain
linked
bound
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023508555A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023537070A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/045012 external-priority patent/WO2022032140A2/en
Publication of JP2023537070A publication Critical patent/JP2023537070A/ja
Publication of JP2023537070A5 publication Critical patent/JP2023537070A5/ja
Pending legal-status Critical Current

Links

JP2023508555A 2020-08-07 2021-08-06 小胞を標的とするタンパク質及びその使用 Pending JP2023537070A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063062844P 2020-08-07 2020-08-07
US63/062,844 2020-08-07
US202163160215P 2021-03-12 2021-03-12
US63/160,215 2021-03-12
PCT/US2021/045012 WO2022032140A2 (en) 2020-08-07 2021-08-06 Vesicle targeting proteins and uses of same

Publications (2)

Publication Number Publication Date
JP2023537070A JP2023537070A (ja) 2023-08-30
JP2023537070A5 true JP2023537070A5 (cg-RX-API-DMAC7.html) 2024-08-14

Family

ID=77821981

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023508555A Pending JP2023537070A (ja) 2020-08-07 2021-08-06 小胞を標的とするタンパク質及びその使用

Country Status (8)

Country Link
US (1) US20240043494A1 (cg-RX-API-DMAC7.html)
EP (1) EP4192515A2 (cg-RX-API-DMAC7.html)
JP (1) JP2023537070A (cg-RX-API-DMAC7.html)
KR (1) KR20230042754A (cg-RX-API-DMAC7.html)
CN (1) CN116209430A (cg-RX-API-DMAC7.html)
AU (1) AU2021320419A1 (cg-RX-API-DMAC7.html)
CA (1) CA3188420A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022032140A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240158824A (ko) * 2023-04-26 2024-11-05 (주)인엑소플랫 면역글로불린 Fc 영역 또는 이의 변이체를 포함하는 재조합 세포외 소포체 및 이를 이용한 세포외 소포체의 분리 방법
WO2025050349A1 (zh) * 2023-09-07 2025-03-13 南京融捷康生物科技有限公司 一种免疫细胞来源细胞外囊泡及其用途
JPWO2025100522A1 (cg-RX-API-DMAC7.html) * 2023-11-10 2025-05-15
TW202545976A (zh) * 2024-02-16 2025-12-01 相佑 林 治療性蛋白質靶向細胞核遞送平臺

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886876A (en) 1983-03-31 1989-12-12 Scripps Clinic And Research Foundation Factor VIII coagulant polypeptides
US4757006A (en) 1983-10-28 1988-07-12 Genetics Institute, Inc. Human factor VIII:C gene and recombinant methods for production
JPH07106156B2 (ja) 1983-10-28 1995-11-15 ジェネティックス、インスティチュ−ト ファクタ−▲viii▼および関連生産物の製造
US5045455A (en) 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression
IL74909A (en) 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
US4965199A (en) 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
EP0182448A3 (en) 1984-08-24 1987-10-28 Genetics Institute, Inc. Production of factor viii and related products
US5595886A (en) 1986-01-27 1997-01-21 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
FI98829C (fi) 1986-01-27 1997-08-25 Chiron Corp Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta
US5422260A (en) 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
US5451521A (en) 1986-05-29 1995-09-19 Genetics Institute, Inc. Procoagulant proteins
US5149637A (en) 1987-04-06 1992-09-22 Scripps Clinic & Research Foundation Recombinant Factor VIIIC fragments
IE69026B1 (en) 1987-06-12 1996-08-07 Immuno Ag Novel proteins with factor VIII activity process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
FR2619314B1 (fr) 1987-08-11 1990-06-15 Transgene Sa Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant
US5004803A (en) 1988-11-14 1991-04-02 Genetics Institute, Inc. Production of procoagulant proteins
DE69032043T2 (de) 1989-11-17 1998-06-04 Chiron Corp Proteinkomplexe mit faktor viii:c-aktivität und deren herstellung
SE465222C5 (sv) 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
US5661008A (en) 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
SE468050C (sv) 1991-03-15 1998-04-27 Pharmacia & Upjohn Ab Rekombinant derivat av human faktor VIII
CA2078721A1 (en) 1991-09-24 1993-03-25 Hiroshi Yonemura Process for preparing human coagulation factor viii protein complex
US5563045A (en) 1992-11-13 1996-10-08 Genetics Institute, Inc. Chimeric procoagulant proteins
WO1994011013A1 (en) 1992-11-13 1994-05-26 Duke University Chimeric blood coagulation proteins
DK0874057T3 (da) 1993-06-10 2004-11-22 Bayer Ag Vektor og pattedyrcellelinie med forbedret produktionsevne
US5658785A (en) 1994-06-06 1997-08-19 Children's Hospital, Inc. Adeno-associated virus materials and methods
US5681746A (en) 1994-12-30 1997-10-28 Chiron Viagene, Inc. Retroviral delivery of full length factor VIII
WO1997003195A1 (en) 1995-07-11 1997-01-30 Chiron Corporation Novel factor viii:c polypeptide analogs with altered protease sites
CA2264482A1 (en) 1996-09-06 1998-03-12 The Trustees Of The University Of Pennsylvania An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
US5948653A (en) 1997-03-21 1999-09-07 Pati; Sushma Sequence alterations using homologous recombination
JP2001517454A (ja) 1997-09-19 2001-10-09 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 組換えアデノ随伴ウイルスの産生に有用な方法および細胞株
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
DE69936104T2 (de) 1998-11-05 2008-01-17 The Trustees Of The University Of Pennsylvania Nukleinsäuresequenzen des adeno-assoziierten virus des serotyps i, und vektoren und wirtszellen, die diese enthalten
US6244113B1 (en) 1999-10-29 2001-06-12 University Of Alabama In Huntsville Method and apparatus for measuring microgravity acceleration
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
EP1463805B1 (en) 2001-12-17 2014-10-22 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
GB0220936D0 (en) * 2002-09-05 2002-10-23 Adprotech Ltd Modified therapeutic agents
WO2016138525A1 (en) * 2015-02-27 2016-09-01 University Of Washington Polypeptide assemblies and methods for the production thereof
US20190151456A1 (en) * 2017-11-17 2019-05-23 Codiak Biosciences, Inc. Compositions of Engineered Exosomes and Methods of Loading Luminal Exosome Payloads
CN108300733B (zh) * 2018-01-19 2021-09-24 华中农业大学 一种基于病原相关分子模式蛋白鉴定具有分泌功能信号肽的方法
EP4059510B1 (en) * 2018-11-16 2025-05-21 Lonza Sales AG Engineered extracellular vesicles and uses thereof

Similar Documents

Publication Publication Date Title
JP2010065037A5 (cg-RX-API-DMAC7.html)
JP2015212284A5 (cg-RX-API-DMAC7.html)
JP2019524645A5 (cg-RX-API-DMAC7.html)
JP2016196472A5 (cg-RX-API-DMAC7.html)
JP2013520172A5 (cg-RX-API-DMAC7.html)
JP2015527366A5 (cg-RX-API-DMAC7.html)
JP2010532978A5 (cg-RX-API-DMAC7.html)
JP2005120106A5 (cg-RX-API-DMAC7.html)
JP2013520426A5 (cg-RX-API-DMAC7.html)
NO20063026L (no) Antistoffer
JP2018537399A5 (cg-RX-API-DMAC7.html)
HRP20200511T1 (hr) Cjepiva protiv bakterija chlamydia sp.
JP2022500409A5 (cg-RX-API-DMAC7.html)
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
JP2018504911A5 (cg-RX-API-DMAC7.html)
JP2004532624A5 (cg-RX-API-DMAC7.html)
JP2019535321A5 (cg-RX-API-DMAC7.html)
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途
JP2010512326A5 (cg-RX-API-DMAC7.html)
JP2015119721A5 (cg-RX-API-DMAC7.html)
JP2022539560A5 (cg-RX-API-DMAC7.html)
JP2025512515A5 (cg-RX-API-DMAC7.html)
JP2023509880A5 (cg-RX-API-DMAC7.html)
JP2018529626A5 (cg-RX-API-DMAC7.html)
JP2016520534A5 (cg-RX-API-DMAC7.html)